Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
申请人:NUEVOLUTION A/S
公开号:US10689383B2
公开(公告)日:2020-06-23
Disclosed are compounds of Formula I, which are active toward nuclear receptors such as nuclear retinoic acid receptor-related orphan receptors (RORs), pharmaceutical compositions containing the compounds of Formula I, and methods of treating inflammatory, metabolic, oncologic and autoimmune diseases or disorders using the of the compounds Formula I in therapy.
公开了对核受体(如核视黄酸受体相关孤儿受体(RORs))具有活性的式 I 化合物、含有式 I 化合物的药物组合物,以及使用式 I 化合物治疗炎症、代谢、肿瘤和自身免疫性疾病或紊乱的方法。